SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-24-023483
Filing Date
2024-06-11
Accepted
2024-06-11 16:30:14
Documents
16
Period of Report
2024-06-06
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 3.02: Unregistered Sales of Equity Securities
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 55961
2 ex10-1.htm EX-10.1 344976
  Complete submission text file 0001493152-24-023483.txt   681977

Data Files

Seq Description Document Type Size
3 XBRL SCHEMA FILE tvgn-20240606.xsd EX-101.SCH 3815
4 XBRL DEFINITION FILE tvgn-20240606_def.xml EX-101.DEF 26691
5 XBRL LABEL FILE tvgn-20240606_lab.xml EX-101.LAB 36844
6 XBRL PRESENTATION FILE tvgn-20240606_pre.xml EX-101.PRE 25315
19 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 5981
Mailing Address 15 INDEPENDENCE BOULEVARD, SUITE 410 WARREN NJ 07059
Business Address 15 INDEPENDENCE BOULEVARD, SUITE 410 WARREN NJ 07059 646-807-8832
Tevogen Bio Holdings Inc. (Filer) CIK: 0001860871 (see all company filings)

IRS No.: 981597194 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41002 | Film No.: 241036208
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)